Catalyst Wire Dossier Catalyst Wire Dossier

aH5N1 vaccine

Influenza vaccine (A/H5N1) · Seqirus
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for aH5N1 vaccine, covering 2016-11-04 to 2016-11-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Underlying Medical Conditions [Phase 3]

See pricing